Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Korngold

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|February 1, 1989
Selective allogenic donor T cell subsets in experimental bone marrow transplantationR Korngold, J Sprent
The Journal of Experimental Medicine|February 1, 1980
Selection of cytotoxic T-cell precursors specific for minor histocompatibility determinants. I. Negative selection across H-2 barriers induced with disrupted cells but not with glutaraldehyde-treated cells: evidence for antigen processingR Korngold, J Sprent
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1991
Graft-versus-host disease in experimental allogeneic bone marrow transplantationR Korngold, J Sprent
Clinics in Haematology|October 1, 1983
Lethal graft-versus-host disease across minor histocompatibility barriers in miceR Korngold, J Sprent
The Journal of Experimental Medicine|December 1, 1978
Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrowR Korngold, J Sprent
Transplantation Proceedings|March 1, 1981
H-2 restriction of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers in miceR Korngold, J Sprent
Immunological Reviews|January 1, 1983
Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complexR Korngold, J Sprent
Immunology Today|October 8, 2014
Immunogenetics of graft-versus-host reactions to minor histocompatibility antigensJ Sprent, R Korngold
Blood|April 15, 1997
A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriersU Koch, R Korngold
Blood|July 27, 2000
Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responsesM H Hsieh, R Korngold
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|February 1, 1989
Selective allogenic donor T cell subsets in experimental bone marrow transplantationR Korngold, J Sprent
The Journal of Experimental Medicine|February 1, 1980
Selection of cytotoxic T-cell precursors specific for minor histocompatibility determinants. I. Negative selection across H-2 barriers induced with disrupted cells but not with glutaraldehyde-treated cells: evidence for antigen processingR Korngold, J Sprent
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1991
Graft-versus-host disease in experimental allogeneic bone marrow transplantationR Korngold, J Sprent
Clinics in Haematology|October 1, 1983
Lethal graft-versus-host disease across minor histocompatibility barriers in miceR Korngold, J Sprent
The Journal of Experimental Medicine|December 1, 1978
Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrowR Korngold, J Sprent
Transplantation Proceedings|March 1, 1981
H-2 restriction of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers in miceR Korngold, J Sprent
Immunological Reviews|January 1, 1983
Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complexR Korngold, J Sprent
Immunology Today|October 8, 2014
Immunogenetics of graft-versus-host reactions to minor histocompatibility antigensJ Sprent, R Korngold
Blood|April 15, 1997
A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriersU Koch, R Korngold
Blood|July 27, 2000
Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responsesM H Hsieh, R Korngold
Pageof 10